April 16 (Reuters) - Drugmaker Apricus Biosciences Inc said on Monday the U.S. regulator directed it to develop a new formulation for its erectile dysfunction cream, Vitaros, which was rejected in February.


00


Reuters

Latest News

Los Angeles Times: Discovery extends CEO David Zaslav's contract through 2023

USA Today: Prosecutors Say Butina Suspected As Russian Spy

USA Today: UNC's Fedora causes stir with CTE comment at ACC media days

USA Today: The Latest: Hokies' Fuente 'not frustrated' by distractions

USA Today: Machado exit could start a trend for underachieving Orioles

USA Today: More claims mean NFL concussion payout could jump by $400M

USA Today: Beilein agrees to extension with automatic rollovers

USA Today: UNC's Fedora causes stir with CTE comment at ACC media days

USA Today: Prosecutors Say Butina Suspected As Russian Spy

USA Today: All five brothers served in the Navy, all five marched for a bucket list wish

USA Today: Walking your dog in Switzerland

Daily Mail: Russian 'agent' held on charges of seeking to...

Daily Mail: Aust breaching standards: Indigenous group

Daily Mail: Cambage rips WNBA for 'ladylike' attempts

Daily Mail: Kourtney Kardashian 'frustrated' by 'jealous' beau Younes Bendjima after slamming her for booty snap

Daily Mail: Zuckerberg: Holocaust deniers won't be banned from...

Daily Mail: The Latest: Hawaii governor offers condolences over ...

Daily Mail: In President Trump, Sen. Rand Paul finds a like-minded...

CNBC: Trump says he holds Putin personally responsible for election meddling

NBC New York: Uber Pushes for Congestion Pricing

Reuters: Biofuel groups ask U.S. government to slow small refinery waiver program

Reuters: U.S. regulatory panel gives Zions Bancorp green light to shed Fed oversight

Reuters: U.S. proposes expedited appeal in fight with AT&T over Time Warner purchase

16 Related Articles, between 2018-04-15 and 2018-04-13